Trial intelligence / Profile preview

Arthrocentesis with hyaluronic acid or platelet-rich plasma for temporomandibular joint disorders

RBR-6dyvm4Recruiting

Sponsor
Universidade Estadual do Rio de Janeiro
Start
May 2019
Countries
1
01

Overview

Randomised, open-label trial of hyaluronic acid and platelet-rich plasma in temporomandibular disorder (TMD) (3 arms), sponsored by Universidade Estadual do Rio de Janeiro. Started May 2019; status: recruiting.

02

Drugs

hyaluronic acidplatelet-rich plasma
03

Conditions

temporomandibular disorder (TMD)

Beyond the preview

Go deeper on RBR-6dyvm4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6dyvm4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call